Atlas Trials

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Clinical trial NCT02735031 · COMPLETED

Trial details

NCT number
NCT02735031
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1Hypoglycemia
Start date
2017-02-21
Primary completion
2018-03-28
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.